KWB Wealth Takes $524,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

KWB Wealth bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 3,816 shares of the financial services provider’s stock, valued at approximately $524,000.

Several other large investors also recently made changes to their positions in the company. Future Financial Wealth Managment LLC acquired a new position in iShares Biotechnology ETF during the 1st quarter valued at about $27,000. Pacifica Partners Inc. lifted its position in shares of iShares Biotechnology ETF by 118.2% during the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after buying an additional 130 shares in the last quarter. Crewe Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 42.9% during the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after buying an additional 78 shares in the last quarter. Northwest Financial Advisors bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $42,000. Finally, Values First Advisors Inc. bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $43,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock traded down $0.93 during mid-day trading on Thursday, hitting $135.09. 1,045,826 shares of the stock were exchanged, compared to its average volume of 1,091,779. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16. The company has a 50-day simple moving average of $135.13 and a 200 day simple moving average of $134.97.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.